Below are the top small-cap biotechnology stocks on the NYSE and the NASDAQ in terms of profit margin.
The trailing-twelve-month profit margin at Enzon Pharmaceuticals Inc ENZN is 92.30 percent. Enzon Pharmaceuticals' EPS for the same period is $0.65.
The trailing-twelve-month profit margin at Enanta Pharmaceuticals Inc ENTA is 65.90 percent. Enanta Pharmaceuticals' revenue for the same period is $124.20 million.
The trailing-twelve-month profit margin at NewLink Genetics Corp NLNK is 59.60 percent. NewLink Genetics' ROE for the same period is 96.50 percent.
The trailing-twelve-month profit margin at Xenon Pharmaceuticals Inc XENE is 59.20 percent. Xenon Pharmaceuticals' PEG ratio is 1.72.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in